Metagenomi, Inc.MGXEarnings & Financial Report
Nasdaq
NextMar 17, 2026
MGX Q3 2025 Key Financial Metrics
Revenue
$8.7M
Gross Profit
N/A
Operating Profit
$-22.8M
Net Profit
$-20.4M
Gross Margin
N/A
Operating Margin
-263.8%
Net Margin
-235.5%
YoY Growth
-24.8%
EPS
$-0.55
Financial Flow
Metagenomi, Inc. Q3 2025 Financial Summary
Metagenomi, Inc. reported revenue of $8.7M for Q3 2025, with a net profit of $-20.4M (-235.5% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $8.7M |
|---|---|
| Net Profit | $-20.4M |
| Gross Margin | N/A |
| Operating Margin | -263.8% |
| Report Period | Q3 2025 |
Metagenomi, Inc. Annual Revenue by Year
Metagenomi, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $52.3M).
| Year | Annual Revenue |
|---|---|
| 2024 | $52.3M |
| 2023 | $44.8M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.4M | $11.2M | $20.0M | $11.5M | $9.6M | $4.1M | $8.5M | $8.7M |
| YoY Growth | N/A | 28.9% | 76.5% | -6.9% | -22.5% | -63.0% | -57.5% | -24.8% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $364.8M | $415.4M | $385.9M | $358.3M | $324.6M | $297.9M | $272.3M | $247.9M |
| Liabilities | $149.7M | $139.8M | $116.5M | $102.6M | $89.7M | $85.2M | $76.5M | $69.5M |
| Equity | $-135.6M | $275.6M | $269.4M | $255.8M | $234.9M | $212.7M | $195.8M | $178.4M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $-29.9M | $-26.3M | $-26.6M | $-26.3M | $-22.8M | $-21.3M | $-21.3M |